70
Participants
Start Date
November 30, 2016
Primary Completion Date
April 30, 2018
Study Completion Date
April 30, 2018
daclatasvir
to evaluate the treatment efficacy and safety of the drug in HCV patients
asunaprevir
to evaluate the treatment efficacy and safety of the drug in HCV patients
Ribavirin
to evaluate the treatment efficacy and safety of the drug in HCV patients
Kaohsiung Medical Universsity, Kaohsiung City
Chang Gung Memorial Hospital
OTHER
National Taiwan University Hospital
OTHER
Taipei Veterans General Hospital, Taiwan
OTHER_GOV
China Medical University Hospital
OTHER
National Cheng-Kung University Hospital
OTHER
Kaohsiung Medical University Chung-Ho Memorial Hospital
OTHER